- The status of all major worldwide harmonization and cooperation initiatives (at bilateral, regional, and global levels)- The value of cooperation in the pharmaceutical sector and the driving factors behind harmonization- The proposition of a structure for the global pharmaceutical system and timely recommendations for enhancing international cooperation, as well as further discussion and policy changes in this area
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Preface About the Author Foreword by Stuart Walker Introduction
Part I: State of Play and Review of Major Cooperation Initiatives Part II: Value and Influencing Factors of Cooperation, Convergence and Harmonization in the Pharmaceutical Sector Part III: Recommendations to Support the Next Phase of International Cooperation, Convergence and Harmonization in the Pharmaceutical Domain Conclusion
Dr. Pierre-Louis Lezotre specializes in global regulatory strategy, and is recognized for his passion and expertise
on international cooperation, convergence, and harmonization of regulations for pharmaceutical
and biotechnology products. He has worked in different cultural environments and lived in
both Europe and the United States.
Dr. Lezotre studied biology (University of Sciences, Saint-Etienne, France)
and drug development (University of Pharmacy, Montpellier, France) from
1992 to 1998. He then received his Master in Regulatory Sciences in 1999 (University
of Pharmacy, Lille, France). He also recently completed his PhD in Law with honors (Doctoral
School of "Law, Politics and Management, University of Law, Lille, France).
Since 1998, Dr. Lezotre has worked for several international pharmaceutical and biotechnology
companies, with increasing levels of responsibility. He has served as a regional and
then global regulatory leader for small molecule and biologic/biotech programs in various
stages of research and development (from early discovery to life cycle management). He
successfully led many global regulatory teams in supporting global registrations of major
products and numerous development projects in several therapeutic areas, including
dermatology, urology, neurology, and pain. He has been responsible for communications
with worldwide Drug Regulatory Authorities and has also worked with external partners/
companies through co-development agreements and business development programs.
Dr. Lezotre has recently been invited to teach courses on international regulation in the
Regulatory Sciences programs of the University of Southern California (USC).